Sachiko Kawasaki‐Yatsugi

YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.

Masao Shimizu‐Sasamata, Sachiko Kawasaki‐Yatsugi, Masamichí Okada et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 88 citations · Full text

Medicine, Neuroscience, Pharmacology +16

Neuroprotective Effect of YM90K, a Novel AMPA/Kainate Receptor Antagonist, in Focal Cerebral Ischemia in Cats

Shin‐ichi Yatsugi, M Takahashi, Sachiko Kawasaki‐Yatsugi et al. · Journal of Cerebral Blood Flow & Metabolism · 1996 · 50 citations

Medicine, Neuroscience, Pharmacology +17

YM872, a novel selective alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, reduces brain damage after permanent focal cerebral ischemia in cats.

M Takahashi, Jian Wei Ni, Sachiko Kawasaki‐Yatsugi et al. · PubMed · 1998 · 48 citations

Medicine, Neuroscience, Pharmacology +15

A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats

Sachiko Kawasaki‐Yatsugi, Shin‐ichi Yatsugi, Masayasu Takahashi et al. · Brain Research · 1998 · 37 citations

Medicine, Neuroscience, Pharmacology +16

Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model

Sachiko Kawasaki‐Yatsugi, Chikako Ichiki, Shin‐ichi Yatsugi et al. · Neuropharmacology · 2000 · 36 citations

Medicine, Neuroscience, Pharmacology +14